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Background
Myocardial fibrosis is known to be associated with
abnormal cardiac remodeling and a poorer prognosis
in patients with hypertrophic cardiomyopathy. Our
purpose was to compare the size of late gadolinium
enhancement (LGE) obtained by cardiac magnetic reso-
nance (CMR) imaging in patients with hypertrophic
cardiomyopathy (HCM) with serum MMP9, which is a
marker of myocardial fibrosis.
Methods
CMR was performed in 50 patients with HCM (mean
age: 54.9 ± 14.1 years, 27 women) using a 1.5 Tesla
scanner (Achieva, Philips). Size of fibrosis was quantified
in percent of total myocardium on inversion-recovery
images after injection of 0,2 ml/kg gadolinium using the
HeAT software and compared with levels of serum
MMP9. A serum level of > 46 ng/ml was regarded as
increased.
Results
Nine out of 50 patients with HCM (18 %) showed no
fibrosis on LGE-CMR. In the remaining 41 patients,
mean size of fibrosis was 13,3 ± 10,3% on LGE-CMR. In
all patients, the mean MMP9 level was 54,4 ± 35,2 ng/
ml. Size of fibrosis on LGE-CMR strongly correlated
with MMP9 levels (R2 = 0,557, Pearson’s r = 0,75, p <
0,01). In the 9 patients with no LGE, MMP9 was with
29,6 ± 14,2 ng/ml significantly lower compared to the
41 patients with LGE and levels of 59,8 ± 36,2 ng/ml
(p = 0,01).
Conclusions
Size of fibrosis on LGE-CMR strongly correlated with
the serum fibrosis marker MMP9 in patients with
HCM. There were no patients with increased fibrosis on
LGE-CMR and normal MMP9, so that an increased
MMP9 makes a myocardial fibroses observed by LGE-
CMR probable. However, 2% of patients revealed no
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Figure 1 Correlation between LGE and MMP 9values (Pearson’s
r = 0,75, p < 0,01).
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LGE despite increased MMP9 levels. These patients may
have a diffuse myocardial fibrosis which is not detect-
able by standard LGE-CMR.
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